Replies to post #208394 on Biotech Values

[DewDiligence]

GNBT/Emmaus—This is effectively a reverse merger with two-way clawback provisions:

https://www.sec.gov/Archives/edgar/data/1059784/000160706217000034/ex10_1.htm